Literature DB >> 2386734

Intermittent blood flow in the KHT sarcoma--flow cytometry studies using Hoechst 33342.

A I Minchinton1, R E Durand, D J Chaplin.   

Abstract

The administration of the fluorescent DNA stain, Hoechst 33342, to mice bearing the KHT sarcoma, combined with flow cytometry, can be used to select cells according to their proximity to functional vasculature. Different protocols of administration of Hoechst 33342 were used in order to differentiate between the presence of temporary and chronically hypoxic cells. The results show a large difference in radiosensitivity between cells close to, and distant from, functional vasculature. However, this pattern of radiosensitivity is observed only when the staining period with Hoechst 33342 is short and coincides with the period of irradiation. When the radiation treatment is temporally divorced from the staining period then the radiosensitivity and staining intensity are not related. This result can be interpreted as indicating that hypoxic cells exist within this tumour as a result of fluctuations in tumour blood flow.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386734      PMCID: PMC1971840          DOI: 10.1038/bjc.1990.259

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue.

Authors:  A Krogh
Journal:  J Physiol       Date:  1919-05-20       Impact factor: 5.182

2.  In vivo studies of x-irradiation damage and repair in mammalian tumor cells.

Authors:  R C Urtasun; T Merz
Journal:  Radiology       Date:  1972-03       Impact factor: 11.105

3.  Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers?

Authors:  J M Henk
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-08       Impact factor: 7.038

4.  The effect of tumor size and host anemia on tumor cell survival after irradiation.

Authors:  R Jirtle; K H Clifton
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 May-Jun       Impact factor: 7.038

5.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

6.  Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors.

Authors:  R F Kallman; G Silini; L M Van Putten
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

7.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

8.  Definitive evidence for hypoxic cells influencing cure in cancer therapy.

Authors:  R S Bush; R D Jenkin; W E Allt; F A Beale; H Bean; A J Dembo; J F Pringle
Journal:  Br J Cancer Suppl       Date:  1978-06

9.  Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

Authors:  J Overgaard; H S Hansen; K Jørgensen; M Hjelm Hansen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

10.  Cell selection from a murine tumour using the fluorescent probe Hoechst 33342.

Authors:  D J Chaplin; R E Durand; P L Olive
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

View more
  15 in total

1.  Microvascular studies on the origins of perfusion-limited hypoxia.

Authors:  M W Dewhirst; H Kimura; S W Rehmus; R D Braun; D Papahadjopoulos; K Hong; T W Secomb
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 2.  Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.

Authors:  C Bayer; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-03-29       Impact factor: 3.621

Review 3.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

4.  Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.

Authors:  Greg M Thurber; Katy S Yang; Thomas Reiner; Rainer H Kohler; Peter Sorger; Tim Mitchison; Ralph Weissleder
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.

Authors:  R D Blumenthal; I Fand; R M Sharkey; O C Boerman; R Kashi; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 6.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response.

Authors:  Mark W Dewhirst; Yiting Cao; Benjamin Moeller
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

7.  Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.

Authors:  M J Trotter; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

8.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

9.  Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.

Authors:  D J Chaplin; M R Horsman; D S Aoki
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.

Authors:  K Newell; P Wood; I Stratford; I Tannock
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.